Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
354 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Show all (7)
  • (-) Currently Recruiting (1)
  • Closed (6)

Medical Condition

  • Show all (15)
  • Cancer (6)
    • Brain Cancer (1)
    • (-) Breast Cancer (1)
    • Gynecologic Cancer (1)
    • Pancreatic Cancer (2)
    • Skin Cancer (1)
  • Healthy Volunteers (1)
  • Heart Disease (2)
  • Infectious Disease (1)
  • Neurological Disorders (2)
  • Obesity (1)
  • Pediatrics (2)
Displaying 1 - 1 of 1

OptimICE-PCR: Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer

Condition: Cancer / Breast Cancer
Investigator: Meghna Trivedi, MD
Status: Currently Recruiting
This study is being done to answer the following question: Among patients with early-stage triple-negative breast cancer (TNBC) who achieve a pathologic complete response (pCR) after preoperative chemotherapy in combination with pembrolizumab, will observation after surgery be as effective as completing 6 more months of…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Contact RecruitMe Terms of Use Privacy Policy ©2025 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science